Coya Therapeutics (COYA) Share-based Compensation Growth (1y) (2023 - 2026)
Coya Therapeutics (COYA) Share-based Compensation Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn | -40.86% |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | - |
| 10 | Coya Therapeutics | 98.05 Mn | 47.33 Mn | - | 575.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 575.87% |
| Dec 31, 2025 | 39.60% |
| Sep 30, 2025 | 725.80% |
| Jun 30, 2025 | 971.99% |
| Mar 31, 2025 | 147.92% |
| Dec 31, 2024 | 232.16% |
| Sep 30, 2024 | 194.96% |
| Jun 30, 2024 | 246.57% |
| Mar 31, 2024 | 141.52% |
| Dec 31, 2023 | 233.20% |
| Sep 30, 2023 | 276.25% |
| Jun 30, 2023 | 327.94% |
| Mar 31, 2023 | 741.95% |